Poppius H, Stenius B
Eur J Clin Pharmacol. 1977 Jan 3;11(2):107-9. doi: 10.1007/BF00562900.
In a double-blind cross-over trial in 13 patients with exercise-induced asthma, doxantrazole 200 mg taken orally 1 hour before a standardized exercise test involving stair climbing failed to block post-exercise bronchoconstriction. In an open assessment study with the same patients, increasing the doxantrazole dose to 400 mg did not affect post-exercise bronchoconstriction.
在一项针对13名运动诱发性哮喘患者的双盲交叉试验中,在涉及爬楼梯的标准化运动试验前1小时口服200毫克多沙唑嗪,未能阻止运动后支气管收缩。在对相同患者进行的开放性评估研究中,将多沙唑嗪剂量增加至400毫克并不影响运动后支气管收缩。